I 11111 1 1 1 1 1 1 l l 1 1 1 I l l 1 1 I l l 11 I I I I I 1 1 1 1 1 I l l 11 I I I I I 1 1 1 1 1 I I I I I 1 1 l l 1 1 1 1 1 1 1 1 l l 1 1 1 1 US006406429Bl (12) United States Patent (io) ABSTRACT Apparatus and method for early detection of cystic structures indicative of ovarian and breast cancers uses ultrasonic wave energy at a unique resonance frequency for inducing cavitation in cystic fluid characteristic of cystic structures in the ovaries associated with ovarian cancer, and in cystic structures in the breast associated with breast cancer. Induced cavitation bubbles in the cystic fluid implode, creating implosion waves which are detected by ultrasonic receiving transducers attached to the abdomen of the patient. Triangulation of the ultrasonic receiving transducers enables the received signals to be processed and analyzed to identify the location and structure of the cyst. The present invention provides such a device, with novel ultrasonography features making the method rapid, accurate, reproducible and capable of automation. The device can be constructed so as to be able to compare standard ultrasonography images with selective induction of ultrasonic cavitation (SINUC) generated images and distinguish cystic from non-cystic structures.
There has yet to be clinically identified any pre-malignant condition which would presage the onset of ovarian cancer. Because most ovarian cancers are cystic in nature, the 1s recognition of an irregular, septate, fluid-filled lesion in the ovary has been the focus of detection by the medical community. Various imaging technologies, including p o s i t r o n e m i s s i o n t o m o g r a p h y ( P E T ) , radioimmunoscintography, magnetic resonance imaging scanning, and ultrasonography, all are capable of detecting cystic structures in the ovary.
The recent addition of color flow Doppler imaging in combination with transvaginal sonography appears to have 2s added another level of sensitivity to the detection of ovarian 2. Description of Background Art Breast cancer is the most common cancer and the second abnormalities, Cohen and jennings (h J Obstet, ~~~ most common cause of cancer-related death in women, with 170:1088-1094) report that endovaginal probes at frequen-175,000 cases and 43,700 deaths projected in 1999 in the cies of 6.5 to 7.5 MHZ provide much finer discrimination of United States. Ovarian cancer is the fourth leading cause of the ovary and uterus than is achievable with transabdominal cancer-related death among females in the United States, 30 ultrasonography. However, the use of various antigen with over 25,000 new cases in 1998 and approximately half markers, in particular Ca 125, in combination with transabthat number in deaths. When diagnosed at an early stage, dominal and transvaginal sonography, or (in one study) there is a very high likelihood of cure for both diseases; magnetic resonance imaging, has failed to achieve the levels however, because of the location and usually asymptomatic of sensitivity and specificity necessary for a highly reliable nature of even relatively advanced ovarian cancer, this type 3s screening technique, of cancer exhibits a high morbidity and mortality rate. sensitive, specific, and Moreover, current methods of breast screening with physical affordable technique for early detection of ovarian and examination and mammography still miss a significant num-breast cancers, ber of breast cancers detectable by ultrasonography.
SUMMARY OF THE INVENTION make precise characterization and accurate follow-up by
The present invention provides a solution to the existing physical examination and mammography problematic. The need in the art by providing a noninvasive technique for the complex nature of the fibrocystic breast in premenopausal early detection of cystic structures using ultrasonic waves, women is a particular challenge to the diagnostician, which potentially at the levels of microns. The present invention is should be especially amenable to characterization by the 45 based on the fact that most ovarian cancers and many breast present invention. Conventional ultrasonography is useful cancers are cystic in nature, consisting of fluid-filled lesions, for examination of a focal region but is neither efficient nor and on the observation by the present inventors that for any reproducible from operator to operator or from visit to visit given fluid (characterized in terms of density, ultrasonic by the same operator.
wave velocity, and viscosity), there exists a characteristic Over two decades ago, there was a major effort to assess SO resonance frequency Or frequency range and a threshold the value of whole breast screening using automated ultra-ultrasound power level at which cavitation bubbles are sonography methodologies. Unfortunately, there were both formed. high false-positive and false-negative rates. Nevertheless, These cavitation bubbles are produced during the rarefaclater studies demonstrated that ultrasonography can detect, tion phase of the ultrasonic wave, and implode to release at least in radiologically dense breasts, cancers not recog-ss shock waves at the pressure phase. The diameter of the Recently, one study found by ultrasonography only three ultrasonic emission, and in the range of approximately 500 cancers per thousand when screening 6113 women with kHz it is on the order of several microns. dense breasts and no symptoms and 687 women with The induction of cavitation and the detection of the palpable or mammographically detected masses. In com-60 resulting implosion waves can be carried out transabdomimenting on these studies, Kopans ("Breast Cancer Screening nally and noninvasively through the skin. The location of the with Ultrasonography," Lancet 354 (9196):2096-7 (1999)) cavitation source producing the implosion wave can be pointed out that although the independent rate of breast identified and used to create a three-dimensional image of cancer detection by ultrasonography alone is not clear, the the cystic fluid structure. The diagnostic procedure accord-"possibility of ultrasonography for breast screening should 65 ing to the invention is rapid, with minimum inconvenience not be ignored". The author further noted that handheld to the patient, thus providing an affordable screening techdevices are operator dependent and expensive, requiring nique.
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This application claims the benefit of the filing date of provisional application Ser. NO. 601149,901, filed Aug. 23, 1999. GOVERNMENT RIGHTS STATEMENT The invention described herein was made with government support under NASA Case No. 20623. The Federal Government has certain rights to this invention.
BACKGROUND OF THE INVENTION
1. Field of the Invention This invention relates generally to medical diagnostic 2o (MRI), compute tomography (CT) imaging, and more particularly to the use of ultrasonic wave generation for early detection of cystic structures in the body, such as in the breast or ovary, the presence of which may indicate the onset of breast cancer or ovarian cancer.
There thus exists a need for a
The presence of multiple cysts and fibronodular structures 40 nized by mammography and physical examination.
cavitation bubbles depends upon the wavelength of the US 6,406,429 B1 3 4
In particular, the present invention provides a method for identifying the presence of cystic structures in any tissue. A first specific application of the invention is as a method for recognizing the presence of cystic structures including ovarian cancers in the ovary, The method includes the steps of applying ultrasonic wave energy to a patient at a frequency causing induction of cavitation in cystic fluid characteristic of and other cystic structures in the tissues of caused by the implosion of cavitation bubbles formed by the i o induction of cavitation, measuring the detected implosion waves, and determining the location of the cavitation source in the body of the patient. A second specific application of the invention is using SINUC to map cystic structures in the According to another aspect of the invention, apparatus for performing the method of detection of cystic structures is provided. frequency of 529 kHz. As shown in FIG. 5 , the use of continuous ultrasonic waves at high energy cause extensive excitation of cavitation and thus increase the temperature to a maximum value at the resonance frequency. The location of the peak of temperature rise as shown in FIG. 5 coincides with a resonant induction of cavitation. Simultaneous measurement of the wave resulting from implosion of the cavitation bubbles, using a hydrophone transducer, showed
The problem Of wave propagation through tissues can be treated as a behavior in viscous fluid, which is described by the governing equation: 5 humans, such as ovarian tissue, detecting implosion waves a significant increase in amp1itude at the Same frequency.
radiologically dense breast.
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Where: PL is fluid density; V is shear viscosity; VB is bulk viscosity; p is pressure; and v is particle velocity.
To determine the pressure field of the ultrasonic wave, this 20 equation needs to be solved using appropriate boundary BRIEF DESCRIPTION OF THE DRAWINGS conditions. Cavitations are formed when the pressure, p, drops below the critical vapor pressure of the fluid, PO. As the ultrasonic wave phase changes, the cavitations are imploded and their collapse characteristics can be analyzed
The present invention can be more fully understood from the detailed description given below in conjunction with the accompanying drawings, These are provided by way of illustration only and are not intended as limiting the present invention, and wherein: is a block diagram of apparatus for analyzing detected cavitation waves to produce images, according to the invention; and is a graph showing the between thermal induction caused by cavitation induced by ultrasonic wave and the frequency of the ultrasonic wave.
Where R is the radius of cavitation; c is sound velocity of the fluid; Pc, is pressure in the liquid at the location of the 35 cavitation center in the absence of the cavitation; Po0 is the far field pressure; and Pb is internal pressure of the cavitation.
The viscosity of the liquid plays an important role in the formation of cavitation. The effect of viscosity is to cause 40 damping and loss of mechanical energy during the growth and collapse process. Consequently, it is expected that an increase in viscosity will lead to a decrease in maximum cavity size and rate of growth and collapse. For liquids with different viscosity, the induced impulse level varies although 45 each is activated by the same acoustic source. Moreover, different wave pressure is needed to form a vapor cavity in Modeling the cavitation phenomenon requires dealing Referring to FIGS. 1A-1B, according to one Preferred with significant nonlinearity and heterogeneity. Nonlineariembodiment, the invention Provides a screening technique SO ties arise from changes in temperature, pressure, stress, for early detection of ovarian cancers which utilizes an strain, strain rate, and other properties associated with the ultrasonic transmitter 12, and a plurality of receivers 16a, input ultrasonic wave. These changes dynamically affect the 16b, and 16c. In a preferred configuration, the receivers mechanical and thermal properties of the propagation 16a-16c are arranged in a triandation array in order to medium, altering wave speed and attenuation. Solving parobtain three-dimensional location information of possible 55 tial differential equations with explicit non-linearity is commalignant structures in the ovary. As shown in FIG. lA, the plicated and tirne consuming, T~ avoid these dificulties, transmitter and receivers are Placed on the abdomen of a linear numerical methods are used. To obtain an analytical patient 10, at a location opposite from ovary 14.
solution to the cavitation problem, incremental linearization The screening technique relies upon the induced forma-can be used. For this type of time-dependent problem, tion at characteristic resonant frequencies of cavitation 60 ''incrementally linear" means advancing the solution in time bubbles in the fluid contained in the cystic structures asso-by discrete increments and modifying the material properties ciated with ovarian cancer. The induced cavitation forms at the end of each increment. Time increments must be small implosion waves having a spectral content that is relatively enough that the solution is linear Over each increment. Using easy to measure and to use to identify the location of the this approach the response of cavitation can be determined cavitation source. 65 US 6,406,429 B3 5 parameters on the induction of cavitation and emission of impulses. The frequency of the input wave can be optimized to produce small cavitation for high sensitivity of detection while accounting for the increased attenuation. The transabdominal sonography using the transmitter as shown in FIGS. 1A-1B thus can selectively induce cavitation in the cystic fluids of the ovary, which in turn produces singularly detectable and identifiable implosion waves. Ultrasound energy is produced at energy levels and durations that does not result in tissue damage. The signals received by the transducers or receivers 16a-16c are used to create a three-dimensional image of ovarian cystic structures. The location of the cyst can be determined using well-established acoustic emission non-destructive testing method technology.
FIG . 2 shows the relationship between the wavelength, phase and cavitation diameter, at a frequency of approximately 25 kHz. As shown, this results in the inducement of a cavitation bubble of approximately 45 microns in radius. Using a frequency on the order of several hundreds of kilohertz would lead to the induction of cavitation bubbles in the range of several microns. The particular resonance frequency for inducing cavitation in cystic fluid conditions representing human ovarian cysts can be identified by subjecting female patients to ultrasonic waves at various frequencies to identify the resonant frequency that uniquely identifies the ovarian cystic fluid. As stated above, in water this condition occurs at 529 kHz. FIG. 3 is an illustration showing the general character of cavitation bubbles induced by a focused ultrasonic transducer 12 using a continuous wave.
In practice, as shown in FIG. 4 , the signals from receiver transducers 16a-16c are inputted to a processor 40, such as a PC, workstation, or other computer, and are processed in conjunction with a triangulation algorithm to obtain a three dimensional image of the cystic structure(s) and its location. As shown in FIGS. 1A-lB, a number of receiving transducers are placed at preselected locations on the patient's abdomen, proximate the plane of the ovary 14. The received signals are analyzed and processed to determine the threedimensional distribution of cavitation source sites. The control parameters of the ultrasonic waves (including pulse rate, duration, amplitude and center frequency) are determined in advance through experimentation, and are selected to ensure that no damage to tissue or to internal organs results from the application of ultrasonic energy. To ensure that the ultrasonic wave does not produce a significant temperature rise in the patient's tissues, short pulses on the order of milliseconds or shorter are used. The control parameters are selected to enable the ultrasonic waves to reach the cavitation excitation threshold level and to selectively induce cavitation in cystic fluid in a manner that maximizes screening sensitivity. Suitable in vivo experimentation can be carried out using artificial cysts of known density in order to identify the values of such control parameters. The identification of a unique resonance frequency for the induction of cavitation in ovarian cysts with minimum excitation in surrounding tissues and organs thus enables the early detection of ovarian cancers at sizes on the order of several microns, thereby significantly increasing the chances for cure by medical intervention at an early stage.
The novel method of the present invention offers a highly sensitive, rapid, non-invasive screening method for patients at high risk for ovarian cancer, and for tracking changes in the size and structures of known abnormalities. A follow-up transvaginal sonography test can be made for detailed evaluation when the ultrasonic screening method of the invention indicates the presence of a potential malignancy.
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A similar transmitter-receiver configuration can be implemented for whole breast scanning.
The method of the present invention also can be used to identify the presence of cystic structures in any human s tissue, in addition to ovarian tissue and breast tissue, and therefore may be used in other diagnostic procedures to identify such structures.
The invention having been thus described, it be apparent to those skilled in the art that the same may be varied in i o many ways without departing from the spirit and scope of the invention. Accordingly, any and all such modifications are intended to be covered by the following claims. What is claimed is: 1. A method for identifying cystic structures in human applying ultrasonic wave energy to a patient at a frequency causing induction of cavitation in cystic fluid characteristic of cystic structures in human tissue; detecting implosion waves caused by the implosion of cavitation bubbles formed by said induction of cavitation; measuring the detected implosion waves to detect the existence of a cystic structure; and determining the location of the cavitation source in the body of the patient from the measured implosion waves. 2. The method of claim 1, wherein the method is used to identify cystic structures in the ovary of a patient, and the step of applying comprises the step of attaching an ultra-3o sonic wave generating transducer to the abdomen of the patient, in the plane of an ovary of the patient. 3. The method of claim 2, wherein the step of detecting comprises the step of attaching at least one ultrasonic receiving transducer to the abdomen of the patient in the 4. The method of claim 3, wherein the step of detecting further comprises the step of attaching a second and third ultrasonic receiving transducer to the abdomen of the patient, one of said second and third receiving transducers 4o being located above the plane of said ovary and the other being located in the plane of said ovary together with said first receiving transducer. 5 . The method of claim 1, wherein the frequency of said ultrasonic wave energy is on the order of hundreds of kilo hertz.
6. The method of claim 1, wherein the method is used to identify cystic structures in the breast of a patient, and the step of applying comprises the step of attaching an ultrasonic wave generating transducer to the breast of the patient.
7.
The method of claim 6, wherein the step of detecting comprises the step of attaching at least one ultrasonic receiving transducer to the breast of the patient. 8. Apparatus for identifying cystic i n tissue, comprising: an ultrasonic wave generator that applies ultrasonic wave energy to a patient at a frequency causing induction of cavitation in cystic fluid characteristic of cystic structures in human tissue; at least one ultrasonic wave receiver that detects implosion waves caused by the implosion of cavitation bubbles formed by said induction of cavitation; a signal processor measuring the detected implosion waves to detect the existence of a cystic structure, and for determining the location of the cavitation source in the body of the patient from the measured implosion 9. Apparatus US 6,406,429 B1 7 8
of the presence of ovarian cancer, and wherein said ultrasonic wave generator comprises an ultrasonic wave generating transducer attachable to the abdomen of the patient, in the plane of an ovary of the patient.
one ultrasonic wave receiver comprises a receiving transducer attachable to the abdomen of the patient in the plane of said ovary.
11.
Apparatus according to claim 10, further comprising second and third ultrasonic receiving transducers attachable i o to the abdomen of the patient, one of said second and third receiving transducers being located above the plane of said ovary and the other being located in the plane of said ovary 12. Apparatus according to claim 8, wherein the frequency of said ultrasonic wave energy is on the order of hundreds of kilohertz, 13. Apparatus according to claim 8, wherein said cystic of the presence of breast cancer, and wherein said ultrasonic wave generator comprises an ultrasonic wave generating 14. Apparatus according to claim 13, wherein said at least one ultrasonic wave receiver comprises a receiving transducer attachable to the breast of the patient. 
